Article
Clinical value of the wild-type estrogen receptor beta expression in breast cancer.
Cancer letters - 26 Feb 2001
Omoto Y, Inoue S, Ogawa S, Toyama T, Yamashita H, Muramatsu M, Kobayashi S, Iwase H
Abstract excerpt
To estimate the clinical value of estrogen receptor (ER) beta expression in breast cancer we used an immunohistochemical method to detect the wild-type ERbeta in 88 primary breast cancers. We used a highly specific polyclonal antibody to the carboxyl terminus of wild-type ERbeta. This antibody reacted with neither other variant forms of ERbeta nor any part of ERalpha. Slides were evaluated on a scale representing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.